Preferred Positioning of Biosimilars a Powerful Lever for Adoption, Says Dr Fran Gregory
There are multiple levers that need to be pulled to allow biosimilars to come to market more broadly in the US, explained Fran Gregory, PharmD, MBA, vice president of emerging therapies, Cardinal Health.